Abstract
A clinical review of 50 adult patients with high level complete spinal lesions, for whom the ORLAU ParaWalker had been prescribed, was undertaken at routine clinical follow-up visits using a questionnaire. The patients had an average age of 31.7 years, an average weight of 68.8 kg, an average height of 1.74 m and 78% had a complete lesion at T9 or above. With an average follow-up period of 34.4 months (min 7 months), 64% were continuing to use the device on a regular basis and more than 78% of those who responded had achieved complete independence. Analysis of the results provides further evidence that the ORLAU ParaWalker is a clinically viable routine treatment for appropriate paraplegic patients with complete mid-thoracic lesions. The need for more precise clinical criteria to further improve the rate of long term use was identified.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
